Search for: "Teva Pharmaceuticals" Results 761 - 780 of 1,429
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Jan 2013, 11:31 am by Paul Greenberg
” The lawsuit alleged that IVAX and its eventual parent company, Teva Pharmaceutical Industries, paid for at least three trips to Miami for Reinstein and several associates, including hotel, airfare, cruises, and dinners. [read post]
21 Jan 2013, 7:27 am by Lawrence B. Ebert
The agency said the problems appear to be associated with the Impax/Teva product.ANDThe U.S. [read post]
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
14 Jan 2013, 6:19 am by Mark Zamora
Although he took only generics, Weeks accused Wyeth, which sold Reglan and is now owned by Pfizer as well as two generic drugmakers – Teva Pharmaceuticals and Actavis – of failing to warn of the risk of long-term use.At issue was whether Weeks could press his lawsuit against Pfizer, a question that a federal court asked the Alabama Supreme Court to decide. [read post]
27 Dec 2012, 3:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2012 WL 1866839, at *5 (W.D. [read post]
30 Nov 2012, 6:00 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
30 Nov 2012, 6:00 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
26 Nov 2012, 4:00 am by Martin Kratz
Sildenafil is the active ingredient in VIAGRA, one of the world's best known pharmaceutical products. [read post]
26 Nov 2012, 4:00 am by Martin Kratz
Sildenafil is the active ingredient in VIAGRA, one of the world's best known pharmaceutical products. [read post]
21 Nov 2012, 11:35 pm by Michael Geist
Teva Pharmaceuticals, one of the world's leading generic pharmaceutical manufacturers, had lost successive challenges against the Viagra patent, but managed to pull out a win when it mattered most. [read post]
13 Nov 2012, 5:43 pm by John W. Arden
The European Commission (EC) announced on November 12 that it has cleared Procter & Gamble Company's proposed acquisition of the over-the-counter (OTC) business of the generic pharmaceutical company Teva Pharmaceutical Industries, Ltd. of Israel. [read post]
1 Nov 2012, 2:37 pm by David Oliver
For those up the line they may, as with the Teva cases we discussed earlier this year, allege negligent and/or defective packaging - i.e. failure to break the doses into the smallest possible units so as to effectively eliminate multiuse and, in large part, compounding, altogether. [read post]
25 Oct 2012, 7:22 am by Christopher Walsh
., of the District of New Jersey has stayed several class-action litigations challenging the legality of certain reverse-payment settlement agreements between Wyeth and generic drug manufacturer Teva Pharmaceuticals, pursuant to which Wyeth allegedly paid Teva to delay its marketing of a generic counterpart to Wyeth’s Effexor XR drug. [read post]
19 Oct 2012, 9:00 am by Matthew Gilpin
One of these was Budaprion XL, made by Impax Laboratories and marketed by Teva Pharmaceuticals. [read post]
9 Oct 2012, 6:31 am by Mark Zamora
The Food and Drug Administration took a highly unusual step this week: It acknowledged that a widely used generic drug -- a copycat of the antidepressant Wellbutrin XL -- was not the equivalent of the original drug produced by GlaxoSmithKline since 2003.The move prompted the world's largest manufacturer of generic drugs, Israel-based Teva Pharmaceuticals, to stop shipping its generic extended-release bupropion -- marketed as Budeprion… [read post]
11 Sep 2012, 5:30 am by Gene Quinn
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]